COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis

被引:0
作者
Justiz-Vaillant, Angel [1 ]
Roopnarine, Kimberly [1 ]
Solomon, Shaundell [1 ]
Phillips, Alyssa [1 ]
Sandy, Solange [1 ]
Subero, Alyssa [1 ]
Seepersad, Sarah [1 ]
Span, Nicholas [1 ]
Ramnath, Phalmanie [1 ]
Ramnarine, Akaasha [1 ]
Ramdath, Bimala [1 ]
Rampaul, Chelsea [1 ]
Ramdial, Renissa [1 ]
Phagoo, Dana [1 ]
Ramdhanie, Thalia [1 ]
Moonilal, Vinaya [1 ]
Poliah, Emily-Marie [1 ]
Poonwassie, Steffan [1 ]
Punilal, Karishta [1 ]
Panchoo, Sarah [1 ]
Parris, Justice [1 ]
Oudit, Steven [1 ]
Muir, Trudy [1 ]
Nicholas-Joseph, Johnson [1 ]
Pandit, Bijey Raj [1 ]
Pakeerah, Sanjeev [1 ]
Sookoo, Vesham [1 ]
Richards, Patrice [1 ]
John, Tishia [1 ]
Gopaul, Darren [2 ]
Soodeen, Sachin [1 ]
Arozarena-Barbosa, Odette [3 ]
Williams, Arlene [1 ]
Unakal, Chandrashehkar [1 ]
Fundora, Rodolfo Arozarena [3 ,4 ]
Thompson, Reinand [1 ]
Akpaka, Patrick Eberechi [1 ]
机构
[1] Univ West Indies, Dept Para Clin Sci, St Augustine Campus, St Augustine 330912, Trinidad Tobago
[2] Morehouse Sch Med, Dept Surg, Atlanta, GA 30310 USA
[3] Eric Williams Med Sci Complex, North Cent Reg Hlth Author, Champs Fleurs 330912, Trinidad Tobago
[4] Univ West Indies, Fac Med Sci, Dept Clin & Surg Sci, St Augustine 330912, Trinidad Tobago
关键词
Pfizer-BioNTech; modern; Novavax; AstraZeneca; Sinopharm; Janssen; vaccine effectiveness (VE); COVID-19; Trinidad and Tobago; MYOCARDITIS; ACCEPTANCE; EFFICACY;
D O I
10.3390/microorganisms13010135
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This systematic review evaluated the effectiveness and side effects of various COVID-19 vaccines, with a focus on Trinidad and Tobago. The Pfizer-BioNTech and Moderna vaccines demonstrated the highest efficacy, particularly against COVID-19 variants, while Janssen and Sinopharm were comparatively less effective. mRNA vaccines, such as Pfizer-BioNTech and Oxford-AstraZeneca, were associated with more frequent and severe side effects, including soreness, fever, and cardiovascular issues. The review also identified significant gaps in the current scientific literature regarding COVID-19 vaccination issues in Trinidad and Tobago. These gaps highlight the need for comprehensive research to address vaccination challenges, including public health communication, equitable access, and local perceptions of vaccine safety. This analysis provides a foundation for developing targeted strategies to improve vaccine effectiveness in the region.
引用
收藏
页数:61
相关论文
共 109 条
  • [1] Cardiac MRI in patients with COVID-19 infection
    Abdeldayem, Emad H.
    Mosaad, Basant M. Raief M.
    Yassin, Aya
    Abdelrahman, Ahmed S.
    [J]. EUROPEAN RADIOLOGY, 2023, 33 (06) : 3867 - 3877
  • [2] Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community
    Abukhalil, Abdallah Damin
    Shatat, Sireen Sultan
    Abushehadeh, Raya Riyad
    Al-Shami, Ni'meh
    Naseef, Hani A.
    Rabba, Abdullah
    [J]. BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [3] Immune thrombocytopenia associated with Pfizer-BioNTech's BNT162b2 mRNA COVID-19 vaccine
    Akiyama, Hiroaki
    Kakiuchi, Seiji
    Rikitake, Junpei
    Matsuba, Hiroyuki
    Sekinada, Daisuke
    Kozuki, Yoko
    Iwata, Nobuko
    [J]. IDCASES, 2021, 25
  • [4] Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
    Alqassieh, Rami
    Suleiman, Aiman
    Abu-Halaweh, Sami
    Santarisi, Abeer
    Shatnawi, Omar
    Shdaifat, Lara
    Tarifi, Amjed
    Al-Tamimi, Mohammad
    Al-Shudifat, Abdel-Ellah
    Alsmadi, Heba
    Al Sharqawi, Ahmed
    Alnawaiseh, Hadeel
    Anasweh, Yara
    Domaidah, Farah Abo
    Abu Jaber, Haneen
    Al-Zarir, Mohammad Rashid
    Bsisu, Isam
    [J]. VACCINES, 2021, 9 (11)
  • [5] Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1016/S1473-3099(22)00309-7, 10.1056/NEJMoa2119451]
  • [6] [Anonymous], 2023, COVID-19 Fortnightly Update
  • [7] [Anonymous], 2022, The Oxford Vaccine Trial
  • [8] Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial
    Asano, Michiko
    Okada, Hiroshi
    Itoh, Yohji
    Hirata, Hajime
    Ishikawa, Kensuke
    Yoshida, Erika
    Matsui, Akiko
    Kelly, Elizabeth J.
    Shoemaker, Kathryn
    Olsson, Urban
    Vekemans, Johan
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 114 : 165 - 174
  • [9] Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
    Bar-On, Yinon M.
    Goldberg, Yair
    Mandel, Micha
    Bodenheimer, Omri
    Freedman, Laurence
    Kalkstein, Nir
    Mizrahi, Barak
    Alroy-Preis, Sharon
    Ash, Nachman
    Milo, Ron
    Huppert, Amit
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15) : 1393 - 1400
  • [10] Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
    Bernal, Jamie Lopez
    Andrews, Nick
    Gower, Charlotte
    Robertson, Chris
    Stowe, Julia
    Tessier, Elise
    Simmons, Ruth
    Cottrell, Simon
    Roberts, Richard
    O'Doherty, Mark
    Brown, Kevin
    Cameron, Claire
    Stockton, Diane
    McMenamin, Jim
    Ramsay, Mary
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 373